Treatment of Visceral Leishmaniasis with Sterically Stabilized Liposomes Containing Camptothecin
AUTOR(ES)
Proulx, Marie-Eve
FONTE
American Society for Microbiology
RESUMO
The efficacy of 20(S)-camptothecin (CPT), free and incorporated into sterically stabilized liposomes, has been investigated in vitro against Leishmania donovani promastigotes and in vivo in a murine model of visceral leishmaniasis. Incubation of L. donovani promastigotes with free or liposomal CPT inhibited the growth of parasites in a dose-dependent manner. Tissue distribution studies revealed that the intraperitoneal administration of liposomal CPT was efficient for the delivery of high drug levels to the liver and spleen. Treatment of infected mice with intraperitoneal injections of free and liposomal CPT significantly reduced the parasite loads in the livers by 43 and 55%, respectively, compared with the loads for untreated controls. However, both treatments caused normochromic anemia and neutropenia.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=90702Documentos Relacionados
- Comparative pharmacokinetics, distributions in tissue, and interactions with blood proteins of conventional and sterically stabilized liposomes containing 2',3'-dideoxyinosine.
- Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy.
- Therapy of Mycobacterium avium complex infections in beige mice with streptomycin encapsulated in sterically stabilized liposomes.
- Treatment of Experimental Visceral Leishmaniasis with Amphotericin B in Stable Albumin Microspheres
- Hexadecylphosphocholine: oral treatment of visceral leishmaniasis in mice.
